Gilead Sciences Inc at Sanford C Bernstein Strategic Decisions Conference Transcript
Okay. Let's go ahead and start. And let's get the last tech people scurry out of the room. We don't need them.
And thank you all for being here for our discussion with Gilead's CFO. And this is going to be a fairly informal discussion. And I'll encourage you to raise your hand and ask some questions. I'll try to make sure the last 5 to 10 minutes are available for you to ask your questions directly -- or you can send them to this pigeonhole application that we do.
But frankly, if you're in the room, I might as well just raise your hand and ask. It's small enough of a group. I was going to cover basically 3 or 4 things. First, the main business HIV then discuss a little bit (inaudible) just because it's kind of an interesting outset potential. Go onto oncology and then kind of ask more about the business development philosophy. And depending how far it will go, trying jumping in on.
So Andrew, thank you being here.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
